Latest Insider Transactions at Revolution Medicines, Inc. (RVMD)
This section provides a real-time view of insider transactions for Revolution Medicines, Inc. (RVMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Revolution Medicines, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Revolution Medicines, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2024
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+0.07%
|
$800
$4.09 P/Share
|
|
Jun 20
2024
|
Elizabeth M Anderson |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+18.88%
|
-
|
|
Jun 20
2024
|
Flavia Borellini |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+17.63%
|
-
|
|
Jun 20
2024
|
Barbara Weber |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+18.88%
|
-
|
|
Jun 20
2024
|
Lorence H. Kim |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+6.37%
|
-
|
|
Jun 20
2024
|
Alexis Borisy |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+0.21%
|
-
|
|
Jun 20
2024
|
Sushil Patel |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+18.97%
|
-
|
|
Jun 20
2024
|
Sandra Horning |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+4.8%
|
-
|
|
Jun 17
2024
|
Lin Wei Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,589
-7.31%
|
$206,793
$37.39 P/Share
|
|
Jun 17
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,757
-3.3%
|
$65,009
$37.39 P/Share
|
|
Jun 17
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
3,349
-1.23%
|
$123,913
$37.39 P/Share
|
|
Jun 17
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,415
-3.13%
|
$163,355
$37.39 P/Share
|
|
Jun 17
2024
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,893
-1.84%
|
$70,041
$37.39 P/Share
|
|
Jun 17
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
11,950
-3.69%
|
$442,150
$37.39 P/Share
|
|
Jun 03
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
7,500
-0.76%
|
$300,000
$40.0 P/Share
|
|
Jun 03
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+2.22%
|
$30,000
$4.09 P/Share
|
|
May 21
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,500
-1.39%
|
$58,500
$39.09 P/Share
|
|
May 03
2024
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-8.93%
|
$400,000
$40.03 P/Share
|
|
May 03
2024
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.2%
|
$20,000
$2.68 P/Share
|
|
Apr 10
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Indirect |
10,000
-14.11%
|
$350,000
$35.34 P/Share
|
|
Apr 10
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
7,500
-1.63%
|
$262,500
$35.48 P/Share
|
|
Apr 10
2024
|
Sushil Patel |
SELL
Open market or private sale
|
Direct |
2,155
-12.07%
|
$79,735
$37.0 P/Share
|
|
Apr 10
2024
|
Sushil Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,155
+10.77%
|
$34,480
$16.8 P/Share
|
|
Mar 27
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,500
-1.35%
|
$45,000
$30.95 P/Share
|
|
Mar 18
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,914
-2.05%
|
$90,334
$31.58 P/Share
|
|
Mar 18
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
2,123
-0.78%
|
$65,813
$31.58 P/Share
|
|
Mar 18
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,252
-2.19%
|
$38,812
$31.58 P/Share
|
|
Mar 18
2024
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,261
-1.22%
|
$39,091
$31.58 P/Share
|
|
Mar 18
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
5,788
-1.24%
|
$179,428
$31.58 P/Share
|
|
Mar 12
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,936
-5.28%
|
$269,824
$34.07 P/Share
|
|
Mar 12
2024
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,936
+5.01%
|
$31,744
$4.09 P/Share
|
|
Mar 11
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
15,735
-9.95%
|
$534,990
$34.02 P/Share
|
|
Mar 11
2024
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,735
+9.05%
|
$62,940
$4.09 P/Share
|
|
Mar 01
2024
|
Mark A Goldsmith |
SELL
Grant, award, or other acquisition
|
Direct |
90,000
-16.18%
|
-
|
|
Mar 01
2024
|
Margaret A Horn Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,000
+22.35%
|
-
|
|
Mar 01
2024
|
Xiaolin Wang |
BUY
Grant, award, or other acquisition
|
Direct |
24,200
+22.26%
|
-
|
|
Mar 01
2024
|
Jack Anders Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,400
+20.37%
|
-
|
|
Mar 01
2024
|
Stephen Michael Kelsey |
BUY
Grant, award, or other acquisition
|
Direct |
51,400
+15.84%
|
-
|
|
Mar 01
2024
|
Jeff Cislini General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
21,000
+26.88%
|
-
|
|
Jan 22
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,500
-3.99%
|
$40,500
$27.0 P/Share
|
|
Jan 08
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
3,337
-1.48%
|
$96,773
$29.01 P/Share
|
|
Jan 02
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
13,330
-5.59%
|
$386,570
$29.1 P/Share
|
|
Dec 27
2023
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
33,334
-12.27%
|
$966,686
$29.01 P/Share
|
|
Dec 18
2023
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,775
-2.27%
|
$44,375
$25.9 P/Share
|
|
Dec 18
2023
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
2,088
-0.76%
|
$52,200
$25.9 P/Share
|
|
Dec 18
2023
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,229
-3.19%
|
$30,725
$25.9 P/Share
|
|
Dec 18
2023
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
8,165
-2.12%
|
$204,125
$25.9 P/Share
|
|
Dec 18
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,993
-2.87%
|
$74,825
$25.9 P/Share
|
|
Dec 15
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.57%
|
$130,000
$26.64 P/Share
|
|
Dec 15
2023
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.37%
|
$20,000
$4.09 P/Share
|